Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polysomnography Study of Seltorexant in Insomnia Disorder
jRCT2080223787Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of seltorexant in Insomnia (5 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Objective sleep parameters by polysomnography. Started Jan 2018; status: completed.
02
Drugs
seltorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCT2080223787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223787.